Innovative Solution for Digital PCR Testing

Thermo Fisher Scientific has introduced its latest research solution for digital PCR called the Applied Biosystems™ QuantStudio™ Absolute Q™ AutoRun dPCR Suite. This advanced system sets itself apart from others in the market by allowing lab automation, which not only reduces overhead costs but also maintains consistency, flexibility, and ease-of-use.

The Applied Biosystems™ QuantStudio™ Absolute Q™ AutoRun dPCR Suite merges the cutting-edge technology of the QuantStudio Absolute Q dPCR system with the intelligent lab automation capabilities of the Thermo™ Scientific™ Spinnaker Microplate Robot. This unique system also features an industry-first multi-plate analysis, allowing for efficient processing of large batches of samples.

By offering an automated and high-throughput solution, this advanced system will assist BioPharma and Molecular research customers in speeding up the time to market of new therapeutics. Additionally, it will provide high-capacity testing capabilities for drug discovery research and development, oncology, Transplant Dx, and other molecular research applications, all while increasing laboratory productivity with minimal hands-on and operator time.

Thermo Fisher's AutoRun is designed around the QuantStudio Absolute Q digital PCR system, which provides a straightforward and accurate means of nucleic acid quantification. The AutoRun offers versatile instrument configurations and intelligent automation that allows for up to 72 hours of hands-free operation, enabling efficient high-throughput multiplex analysis with a streamlined, walk-away workflow.

更多的信息online